dna cdna transcription kit (Thermo Fisher)
Structured Review

Dna Cdna Transcription Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 100470 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna cdna transcription kit/product/Thermo Fisher
Average 98 stars, based on 100470 article reviews
Images
1) Product Images from "Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target"
Article Title: Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target
Journal: NAR Cancer
doi: 10.1093/narcan/zcaf058
Figure Legend Snippet: Nucleolar-targeting compounds inhibit nucleolar activity and induce selective DNA damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA transcription in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).
Techniques Used: Activity Assay, Control, Staining
![E–P distances of selected differentially expressed genes show small changes during differentiation from naive to primed mESCs. (A) Cell culture model of naive to primed transition in mESCs. (B) Changes in Nanog <t>transcription</t> levels (% GAPDH transcription) in naive and primed cells measured by qRT-PCR. The graph depicts median ± standard error of the mean ( n = 5 biological replicates). (C) Nanog genomic region for naive and primed cells, showing from top to bottom: <t>DNA</t> oligoFISH and NOVA FISH probes against promoter and selected enhancers, all predicted enhancers, connection of Nanog promoter to its enhancers, H3K27ac ChiP signal (from ), ATAC-seq signal (from ), CTCF binding motifs, and targeted enhancer regions (vertical gray stripes). Functionally validated enhancers are marked by ◆ . (D) Experimental workflow: regions of interest are marked with two-color DNA oligoFISH, the samples are imaged automatically with spinning disk confocal microscopy, FISH spots are detected automatically with subpixel localization accuracy and 3D distances between matched E–P spots are calculated to produce a E–P distance distribution of the population. Scale bar represents 1 μm. (E) 3D distance [μm] distributions between Nanog promoter and its −5, −45, +60, and +105 (putative) enhancers in naive and primed cells. Dashed line and number next to the histogram represent the median distance. The changes between naive and primed cells are not significant ( P > 0.05, two-sided Wilcoxon rank sum test, BH correction). From closest to furthest enhancer: n naive = 916, 1718, 837, 1220; n primed = 1037, 1038, 1362, 701; three biological replicates each. (F) Change in median 3D E–P distance [μm] of genes down- and up-regulated during the naive to primed transition. E–P pairs above the diagonal show increased distances during differentiation, while distance in pairs below the diagonal decreases. Each circle refers to a different enhancer. The test of statistical significance is the same as in panel (E). Functionally validated enhancers are marked by ◆ .](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4394/pmc12684394/pmc12684394__gkaf1255fig1.jpg)